Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion.

Clin Ophthalmol · 2018 · PMC6038867 · PMID 30013316

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

borderline significantp =0.059so close (0.05 < p ≤ 0.1)

In the IVIA group, the IOP seemed to be higher after 1 month of injection, changing from 14.4±3.1 mmHg at baseline to 15.3±3.0 mmHg at 1 month (borderline significant, p =0.059).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.